Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 10,141 | 3,263 | 2,118 | 0 | 633 |
| Operating Income | -10,141 | -3,263 | -2,118 | N/A | -633 |
| Other Income | 4 | 13 | 161 | 0 | -48 |
| Pre-tax Income | -10,137 | -3,250 | -1,957 | 0 | -681 |
| Income Tax | -1 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -10,136 | -3,250 | -1,957 | N/A | -681 |
| Net Income | $-10,136 | $-3,250 | $-1,957 | $N/A | $-681 |
| EPS Basic Total Ops | -3.71 | -1.23 | -0.74 | N/A | -0.28 |
| EPS Basic Continuous Ops | -3.71 | -1.23 | -0.74 | N/A | -0.28 |
| EPS Diluted Total Ops | -3.71 | -1.23 | -0.74 | N/A | -0.28 |
| EPS Diluted Continuous Ops | -3.71 | -1.23 | -0.74 | N/A | -0.28 |
| EBITDA(a) | $-10,061 | $-3,220 | $-2,091 | $N/A | $-633 |